Literature DB >> 21881524

Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study.

Giovanni Cioffi1, Pompilio Faggiano, Donata Lucci, Andrea Di Lenarda, Gian Francesco Mureddu, Luigi Tarantini, Paolo Verdecchia, Marco Comaschi, Carlo B Giorda, Mario Velussi, Marcello Chinali, Roberto Latini, Serge Masson, Giovanni De Simone.   

Abstract

BACKGROUND: An inappropriately high left ventricular mass (iLVM) may be detected in patients with diabetes mellitus. Several hemodynamic and nonhemodynamic factors stimulating LVM growth may actively operate in these patients. In this study, we assessed prevalence and factors associated with iLVM in patients with diabetes mellitus.
METHODS: We analyzed baseline data from 708 patients (61 ± 7 years, 57% treated for hypertension) with type 2 diabetes mellitus without evidence of cardiac disease enrolled in the left ventricular dysfunction in diabetes study. iLVM was diagnosed by Doppler echocardiography as LVM more than 28% of the expected LVM predicted from height, sex and stroke work.
RESULTS: iLVM was detected in 166 patients (23%), irrespective of concomitant hypertension. Patients with iLVM were more frequently women, had higher BMI and prevalence of metabolic syndrome, higher serum triglyceride levels and were treated more frequently with metformin and diuretics. In a multivariate model, female sex [odds ratio (OR) 1.502 (95% confidence interval (CI) 1.010-2.231), P = 0.04], higher serum triglyceride levels [OR 1.007 (95% CI 1.003-1.012), P < 0.001] and BMI [OR 1.220 (95% CI 1.116-1.335), P < 0.001] emerged independently related to iLVM.
CONCLUSION: iLVM is detectable in about a quarter of patients with type 2 diabetes mellitus without evidence of cardiac disease and is unrelated to blood pressure levels. The association between LVM and some components of metabolic syndrome in these patients may have important practical implications.

Entities:  

Mesh:

Year:  2011        PMID: 21881524     DOI: 10.1097/HJH.0b013e32834acc6d

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  7 in total

1.  Combined circumferential and longitudinal left ventricular systolic dysfunction in patients with type 2 diabetes mellitus without myocardial ischemia.

Authors:  Giovanni Cioffi; Giorgio Faganello; Stefania De Feo; Nicola Berlinghieri; Luigi Tarantini; Andrea Di Lenarda; Bruno Pinamonti; Riccardo Candido; Pompilio Faggiano
Journal:  Exp Clin Cardiol       Date:  2013

2.  Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study.

Authors:  Giovanni de Simone; Wenyu Wang; Lyle G Best; Fawn Yeh; Raffaele Izzo; Costantino Mancusi; Mary J Roman; Elisa T Lee; Barbara V Howard; Richard B Devereux
Journal:  Cardiovasc Diabetol       Date:  2017-05-12       Impact factor: 9.951

3.  Inappropriate Left Ventricular Mass and Cardiovascular Disease Events and Mortality in Blacks: The Jackson Heart Study.

Authors:  D Edmund Anstey; Rikki M Tanner; John N Booth; Adam P Bress; Keith M Diaz; Mario Sims; Gbenga Ogedegbe; Paul Muntner; Marwah Abdalla
Journal:  J Am Heart Assoc       Date:  2019-08-13       Impact factor: 5.501

Review 4.  Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease.

Authors:  Milton Packer; Carolyn S P Lam; Lars H Lund; Mathew S Maurer; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2020-06-26       Impact factor: 15.534

5.  Hyperuricemia Is Associated with Left Ventricular Dysfunction and Inappropriate Left Ventricular Mass in Chronic Kidney Disease.

Authors:  Tai-Hua Chiu; Pei-Yu Wu; Jiun-Chi Huang; Ho-Ming Su; Szu-Chia Chen; Jer-Ming Chang; Hung-Chun Chen
Journal:  Diagnostics (Basel)       Date:  2020-07-24

6.  Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain.

Authors:  Saskia M Rombach; Bouwien E Smid; Machtelt G Bouwman; Gabor E Linthorst; Marcel G W Dijkgraaf; Carla E M Hollak
Journal:  Orphanet J Rare Dis       Date:  2013-03-25       Impact factor: 4.123

Review 7.  Cardiotoxicity with vascular endothelial growth factor inhibitor therapy.

Authors:  Rhian M Touyz; Joerg Herrmann
Journal:  NPJ Precis Oncol       Date:  2018-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.